Anxiolytic compositions containing dioxopiperidine derivatives

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/228

A61K 31/445 (2006.01)

Patent

CA 1316112

ABSTRACT ANXIOLYTIC COMPOSITIONS CONTAINING DIOXOPIPERIDINE DERIVATIVES Phenyl-3-aminoalkyl-4-methyl-2,6-dioxopiperidines of the Formula I Image (I) wherein: R1 represents hydrogen or C1-C4 alkyl; n is 1 or 2; R2 represents hydrogen or methyl, provided that one R2 is hydrogen when n is 2; R3 represents hydrogen or C1-C2 alkyl; R4 represents C1-C2 alkyl; R5 and R6 independently represent hydrogen or methyl; m is 0 to 3; and each Y is in a meta or para position and independently represents hydroxy, C1-C2 alkoxy, C1-C2 alkyl, C1-C2 hydroxyalkyl, halogen, or trifluoromethyl, provided that hydroxy and alkoxy are not in the para position, and pharmacologically acceptable salts thereof have anxiolytic activity. At least some of the compounds are ten orders more potent than diazepam, exhibit an effective dose range in the order of millions fold, and cause dose related effects without sedative side effects. The presently preferred compound is 3-(3'methoxyphenyl)-3-(3"-N,N-dimethylaminopropyl) -4,4-dimethyl-2,6-dioxopiperidine (AGN 2979).

546240

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anxiolytic compositions containing dioxopiperidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anxiolytic compositions containing dioxopiperidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anxiolytic compositions containing dioxopiperidine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1252509

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.